Christopher Ring in Williamsport, Pennsylvania

Home Pennsylvania Williamsport

Christopher Ring has Nurse Practitioner as his primary medical specialty. Their primary office is: 700 High St in Williamsport, Pennsylvania.

They're a part of the: Susquehanna Physician Services medical group which has around 469 members. You can call their office at - to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2017 (around 7 years of experience). They are listed as doing telehealth appointments.

Christopher Jason Ring Office Phone and Directions

Christopher Ring
Susquehanna Physician Services
700 High St
Williamsport, Pennsylvania 17701
-

Patient Ratings
Please rate your experience with Christopher Ring below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Enter a starting address:

Healthcare Info for Christopher Ring

Medical School: Sorry, his university is not listed
Graduation Year: 2017
The Primary Medical Specialty for Christopher Ring is listed as: Nurse Practitioner
Approximate Years of Experience: 7
PAC (PECOS ID)#: 7214297340
NPI #: 1184137366
NPI Created On: 11/10/2017
NPI Last Updated Listed as: 06/15/2021
Primary Taxonomy Code: 363L00000X
License Number:
SP018081
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Hospital observation care, typically 50 minutes
Hospital observation care, typically 70 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Record ID:: 818287523

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CNS

Name of Drug #1: VIVITROL

Open Associated Drug #1: 65757-300-01

Payments Total: $22